BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33941276)

  • 1. Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis.
    Peikert K; Federti E; Matte A; Constantin G; Pietronigro EC; Fabene PF; Defilippi P; Turco E; Del Gallo F; Pucci P; Amoresano A; Illiano A; Cozzolino F; Monti M; Garello F; Terreno E; Alper SL; Glaß H; Pelzl L; Akgün K; Ziemssen T; Ordemann R; Lang F; Brunati AM; Tibaldi E; Andolfo I; Iolascon A; Bertini G; Buffelli M; Zancanaro C; Lorenzetto E; Siciliano A; Bonifacio M; Danek A; Walker RH; Hermann A; De Franceschi L
    Acta Neuropathol Commun; 2021 May; 9(1):81. PubMed ID: 33941276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological and Pathogenesis Significance of Chorein in Health and Disease.
    Alkahtani S; Alkahtane AA; Alarifi S
    Physiol Res; 2024 Apr; 73(2):189-203. PubMed ID: 38710051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of four novel mutations in VSP13A in Iranian patients with Chorea-acanthocytosis (ChAc).
    Ghodsinezhad V; Ghoreishi A; Rohani M; Dadfar M; Mohammadzadeh A; Rostami A; Rahimi H
    Mol Genet Genomics; 2024 Mar; 299(1):39. PubMed ID: 38519717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel heterozygous VPS13A pathogenic variants in chorea-neuroacanthocytosis: a case report.
    Chen X; Zhang P; Wang L; Zhang Y
    BMC Neurol; 2023 Oct; 23(1):350. PubMed ID: 37794323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chorea-acanthocytosis patient with novel mutations in the VPS13A gene without acanthocyte.
    Jin S; Sun Z; Fang X; Chen H; Yang W; Wang S; Fan J
    Neurol Sci; 2024 May; 45(5):2057-2061. PubMed ID: 37985634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Autopsy Series of Seven Cases of VPS13A Disease (Chorea-Acanthocytosis).
    Ditzel RM; Walker RH; Nirenberg MJ; Tetlow AM; Farrell K; Lind-Watson KJ; Thorn EL; Dangoor DK; Gordon R; De Sanctis C; Barton B; Karp BI; Kirby A; Lett DJ; Mente K; Simon DK; Velayos-Baeza A; Miltenberger-Miltenyi G; Humphrey J; Crary JF
    Mov Disord; 2023 Dec; 38(12):2163-2172. PubMed ID: 37670483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eighth International Chorea-Acanthocytosis Symposium: Summary of Workshop Discussion and Action Points.
    Pappas SS; Bonifacino J; Danek A; Dauer WT; De M; De Franceschi L; DiPaolo G; Fuller R; Haucke V; Hermann A; Kornmann B; Landwehrmeyer B; Levin J; Neiman AM; Rudnicki DD; Sibon O; Velayos-Baeza A; Vonk JJ; Walker RH; Weisman LS; Albin RL
    Tremor Other Hyperkinet Mov (N Y); 2017; 7():428. PubMed ID: 28224046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chorea-acanthocytosis genotype in the original critchley kentucky neuroacanthocytosis kindred.
    Velayos-Baeza A; Holinski-Feder E; Neitzel B; Bader B; Critchley EM; Monaco AP; Danek A; Walker RH
    Arch Neurol; 2011 Oct; 68(10):1330-3. PubMed ID: 21987550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VPS13A knockdown impairs corticostriatal synaptic plasticity and locomotor behavior in a new mouse model of chorea-acanthocytosis.
    García-García E; Ramón-Lainez A; Conde-Berriozabal S; Del Toro D; Escaramis G; Giralt A; Masana M; Alberch J; Rodríguez MJ
    Neurobiol Dis; 2023 Oct; 187():106292. PubMed ID: 37714309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Neuroacanthocytosis" - Overdue for a Taxonomic Update.
    Walker RH; Danek A
    Tremor Other Hyperkinet Mov (N Y); 2021 Jan; 11():1. PubMed ID: 33510935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chorea-acanthocytosis.
    Rashid S; Malek N; Krommyda M
    Pract Neurol; 2024 May; 24(3):223-225. PubMed ID: 38290845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Chorein Deficiency in Late Spermatogenesis.
    Arai K; Nishizawa Y; Nagata O; Sakimoto H; Sasaki N; Sano A; Nakamura M
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38275411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroacanthocytosis Syndromes: The Clinical Perspective.
    Walker RH; Peikert K; Jung HH; Hermann A; Danek A
    Contact (Thousand Oaks); 2023; 6():25152564231210339. PubMed ID: 38090146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: Misdiagnosed orolingual dyskinesia as a consequence of seizures in a chorea-acanthocytosis patient with a novel
    Wang M; Li H; Zhou Q; Zhao Q; Wang M; Geng Y; Kang H
    Front Neurol; 2024; 15():1352467. PubMed ID: 38933328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythroid Differentiation Dependent Interaction of VPS13A with XK at the Plasma Membrane of K562 Cells.
    Amos C; Xu P; De Camilli P
    Contact (Thousand Oaks); 2023; 6():25152564231215133. PubMed ID: 38144430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of E255K/V-inclusive mutations in a Philadelphia-positive acute lymphoblastic leukemia with mutation evolution during sequential TKIs therapies: A case report.
    Zhao M; Gui X; Wu Q; Xia L; Wang Y
    Medicine (Baltimore); 2021 May; 100(18):e25579. PubMed ID: 33950935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.
    Peikert K; Glaß H; Federti E; Matte A; Pelzl L; Akgün K; Ziemssen T; Ordemann R; Lang F; Patients TNFTRFN; De Franceschi L; Hermann A
    J Pers Med; 2021 May; 11(5):. PubMed ID: 34068769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
    Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
    Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report.
    Kuge T; Okabe F; Yamamoto Y; Ishijima M; Uenami T; Kanazu M; Akazawa Y; Yano Y; Yamaguchi T; Mori M
    Thorac Cancer; 2021 Jun; 12(12):1935-1939. PubMed ID: 33973724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma.
    El-Khouly FE; Veldhuijzen van Zanten SEM; Jansen MHA; Bakker DP; Sanchez Aliaga E; Hendrikse NH; Vandertop WP; van Vuurden DG; Kaspers GJL
    J Neurooncol; 2021 Jun; 153(2):263-271. PubMed ID: 33963476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.